This inventor holds 1 USPTO granted patent. Top assignee: Ningbo Combireg Pharmaceutical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Wenjun Yu
Introduction
Wenjun Yu is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. His work focuses on enhancing the efficacy and safety of medicinal compounds.
Latest Patents
Wenjun Yu holds a patent for a deuterated 1,4-benzodiazepine-2,5-dione compound and its use. This innovative compound is designed to inhibit tumor cells and tumor stem cells effectively. The patent highlights the compound's ability to prolong the degradation function of in-vitro human liver microsomes, significantly extending its half-life. This advancement presents a safer and more reliable candidate for the development of new anti-tumor drugs.
Career Highlights
Wenjun Yu is associated with Ningbo Combireg Pharmaceutical Technology Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation in drug development has positioned him as a key figure in the industry.
Collaborations
Wenjun Yu collaborates with talented professionals such as Gang Liu and Yao Ma. Their combined expertise fosters a dynamic environment for research and development.
Conclusion
Wenjun Yu's contributions to pharmaceutical innovation, particularly in anti-tumor drug development, underscore his importance in the field. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile